Office of Generic Drugs 2022 Annual Report – Healthcare Economist

0
226
Office of Generic Drugs 2022 Annual Report – Healthcare Economist


FDA’s Office of Generic Drugs issued their 2022 Annual Report. Generic medication play a significant position in saving sufferers and payers cash. To give an instance, pregabalin capsules value $450 for a 30-day provide throughout the finish of its market exclusivity interval, however priced dropped to $23 (a 95% lower) throughout the first 12 months after generic entry. For this drug alone, financial savings to the healthcare system was $6.6 billion. skilled a 95% value discount throughout the first 12 months of generic gross sales.

In 2022, the Office of Generic Drugs accepted 106 first generic medication. Below are some highlights from the report.

Office of Generic Drugs 2022 Annual Report – Healthcare Economist
https://www.fda.gov/media/165435/download#page=8
https://www.fda.gov/media/165435/download#page=8

LEAVE A REPLY

Please enter your comment!
Please enter your name here